History | Fractures (non-complex): assessment and management | Guidance | NICE

Guidance
Skip Standards and indicators submenu
Quality standards
Our quality standards set out priority areas for quality improvement. They highlight areas with identified variation in current practice.
View our quality standards
How to use our quality standards
The timeline for developing quality standards
Help us develop quality standards
Selecting and prioritising quality standards topics
About quality standards
Indicators
Our indicators measure outcomes that reflect the quality of care, or processes linked by evidence to improved outcomes.
View list of indicators
Learn about the committee that develops indicators
About indicators
Skip Life sciences submenu
Life Sciences
We offer tailored support to industry during product development. Our expertise can help you build the evidence needed to achieve market access.
View life sciences
Get support from NICE
NICE Advice service
Trusted, unrivalled expertise.
Make an enquiry
Contact us to discuss your requirements.
Innovative Licensing and Access Pathway (ILAP)
Streamlining patient access to safe, financially sustainable and innovative medicines.
Learn how we evaluate technologies
Health technology evaluation and topic selection manuals
Updated manuals for methods, processes and topic selection.
Digital health technologies
Accelerating our efforts to deliver innovation to the health and care system.
Evidence standards framework
Using the best available evidence to develop recommendations that guide decisions in health, public health and social care.
Our guidance programmes
Ensuring new technologies are clinically effective and offer economic value.
Register your product
Non-pharmaceutical
NHS Innovation Service is a clear and simple point of entry for health technologies to access support and national evaluation programmes.
Pharmaceutical
UK PharmaScan is a database of new medicines, indications and formulations in the pharmaceutical pipeline.
Find published and proposed evaluations
Diagnostics
Guidance on measurements and tests used to evaluate a patient's condition.
Medical technologies
Guidance on medical technologies put forward to NICE by manufacturers.
Technology appraisals
Guidance on new and existing medicines and treatments in the NHS.
Highly specialised technologies
Guidance on the use of highly specialised medicines and treatments.
British National Formulary (BNF)
British National Formulary for Children (BNFC)
Clinical Knowledge Summaries (CKS)
Skip About submenu
About
NICE helps practitioners and commissioners get the best care to patients, fast, while ensuring value for the taxpayer.
Explore about
Our programmes
Learn about the information we produce.
Guidance
Advice
Quality standards
Indicators
Digital health
Topic selection
Get involved
Understand how decisions are made:
Attend a committee meeting
Comment on draft guidance:
Guidance in consultation
Be part of a guidance committee:
Join a committee
Help develop our products:
Register as a stakeholder
Putting you at the heart of our work:
Public involvement
What we do
Social care
Life sciences
NICE international
Patient safety
Shared decision making
Into practice
Social care quick guides
Measuring the use of NICE guidance
Resource planner
View all Into practice
Who we are
The board
The NICE strategy 2021 to 2026
Corporate publications
View all Who we are
- Contact us
- Jobs

History

Equality and health inequalities assessment

Equality impact assessment (PDF 237 KB)

Published:

17 February 2016

Stakeholder list updated

Stakeholder list (PDF 108 KB)

Published:

17 February 2016

Consultation comments published

Consultation comments and responses (PDF 650 KB)

Published:

17 February 2016

Committee meetings

Committee meeting: 10 & 11
Minutes 10 & 11 (PDF 120 KB)

Published:

25 February 2016
Minutes 12 (PDF 132 KB)

Published:

25 February 2016

Draft guideline consultation

Draft guideline consultation information
Full guideline (PDF 2.23 MB)

Published:

07 August 2015
Draft guideline (NICE) (PDF 289 KB)

Published:

07 August 2015
Equality impact assessment (PDF 220 KB)

Published:

07 August 2015
Appendices
Appendices A-F (PDF 1.93 MB)

Published:

07 August 2015
Appendices G-I (PDF 2.89 MB)

Published:

07 August 2015
Appendices J-Q (PDF 1.6 MB)

Published:

07 August 2015

Guideline development and consultation

Guideline development and consultation
Review questions (PDF 176 KB)

Published:

17 June 2015
Search strategies (PDF 666 KB)

Published:

23 July 2015
Health economic plan (PDF 57 KB)

Published:

17 June 2015
GDG members (PDF 199 KB)

Published:

17 February 2014
GDG minutes
GDG NCF8-9 Minutes 13-14 Aug 2014 (PDF 136 KB)

Published:

18 September 2015
GDG NCF6-7 Minutes 23 Jul 2014 (PDF 151 KB)

Published:

04 September 2014
GDG NCF4-5 Minutes 21-22 May 2014 (PDF 161 KB)

Published:

04 September 2014
GDG NCF3 Minutes 09 Apr 2014 (PDF 151 KB)

Published:

04 September 2014
GDG NCF2 Minutes 16 Jan 2014 (PDF 149 KB)

Published:

04 September 2014

Scoping workshop, consultation and final scope

Scoping workshop, consultation and final scope
Scoping EIA form (PDF 150 KB)

Published:

19 November 2013
Consultation table with responses (PDF 267 KB)

Published:

03 September 2013
Final scope (PDF 167 KB)

Published:

03 September 2013
Scope consultation information
Draft scope (PDF 154 KB)

Published:

28 February 2013
Stakeholder list (PDF 24 KB)

Published:

17 June 2015